Medicare's Cost-Sharing for Preventive Vaccines

The U.S. Food and Drug Administration will convene an expert advisory panel in April to consider requests from Pfizer and Moderna to authorize a fourth dose of their COVID-19 vaccines. Pfizer is seeking authorization for people aged 65 and older.